Future Current

A pioneer in the field of stem cell research, Michael West, Ph.D., has served on the BioTime Board of Directors since 2002 and has extensive academic and business experience in age-related degenerative diseases, telomerase molecular biology and human embryonic stem cell research and development. At the free symposium organized by the Methuselah Foundation life-extension organization, he unveiled an online open sourced database, called the Embryome, whose purpose is to help identify the hundreds of cell types that can be made from embryonic stem cells.

Read the rest of this entry »

Gregory Stock is a biophysicist, best-selling author, biotech entrepreneur, and the director of the Program on Medicine, Technology and Society at UCLA’s School of Medicine. He has written extensively on the implications for society, medicine and business of the human genome project and associated developments in molecular genetics and bioinformatics. His interests lie in the scientific and evolutionary as well as ethical, social and political implications of today’s revolutions in the life sciences and in information technology and computers.

Read the rest of this entry »

Aubrey de Grey of the Methuselah Foundation and Tanya Jones of Alcor Life Extension

The free public event preceding the Understanding Aging conference organized by the Methuselah Foundation was entitled “Aging: the disease, the cure, the implications.” Held in Royce Hall at UCLA on the evening of June 27th, 2008, the event aimed at putting the postponement of aging more firmly on the political and social map than ever before. There, biogerontologist Aubrey de Grey offered his own underlying arguments for why aging can and should be the target of current-day regenerative medicine.

Read the rest of this entry »

The Methuselah Foundation is a 501c(3) non-profit organization committed to the acceleration of progress toward a cure for age-related disease. Biogerontologist Aubrey de Grey has formulated a wide-ranging plan for the comprehensive and eventually indefinite postponement of age-related physical and mental decline, named Strategies for Engineered Negligible Senescence. He is the organizer of an ongoing series of conferences and workshops that focus on the key biomedical research relevant to SENS, the most recent of which was entitled “Aging: the disease, the cure, the implications.”

Read the rest of this entry »